The Economic Case for Ketamine: How Expanded Access Could Save Lives and Money
Healthcare costs in the United States continue to rise at an alarming rate, with mental health treatment representing a significant and growing portion of these expenses. Among mental health conditions, treatment-resistant depression stands out as particularly costly, both in terms of direct medical expenses and...